| dc.contributor | Vall d'Hebron Barcelona Hospital Campus |
| dc.contributor.author | Arce Gallego, Sara |
| dc.contributor.author | Romero-Lozano, Paula |
| dc.contributor.author | Mir Arnau, Gisela |
| dc.contributor.author | Aguilar, Daniel |
| dc.contributor.author | Mast, Richard |
| dc.contributor.author | Cresta Morgado, Pablo |
| dc.contributor.author | Delgado-Serrano, Luisa |
| dc.contributor.author | Simonetti, Sara |
| dc.contributor.author | Macarena, Gonzalez |
| dc.contributor.author | Marmolejo Castañeda, David Humberto |
| dc.contributor.author | Morales-Barrera, Rafael |
| dc.contributor.author | Semidey Raven, Maria Eugenia |
| dc.contributor.author | Cordoba, Sarai |
| dc.contributor.author | de Albert de Delás-Vigo, Matias |
| dc.contributor.author | Planas, Jacques |
| dc.contributor.author | Cuadras Solé, Mercè |
| dc.contributor.author | Maldonado, Xavier |
| dc.contributor.author | Casanova-Salas, Irene |
| dc.contributor.author | Mas Malavila, Alba |
| dc.contributor.author | Nonell, Lara |
| dc.contributor.author | Dienstmann, Rodrigo |
| dc.contributor.author | Nuciforo, Paolo |
| dc.contributor.author | Vivancos, Ana |
| dc.contributor.author | Llop-Guevara, Alba |
| dc.contributor.author | Serra, Violeta |
| dc.contributor.author | Mateo, Joaquin |
| dc.contributor.author | Carles, Joan |
| dc.contributor.author | Suárez, Cristina |
| dc.date.accessioned | 2025-03-31T09:57:47Z |
| dc.date.available | 2025-03-31T09:57:47Z |
| dc.date.issued | 2025-02-18 |
| dc.identifier.citation | Arce-Gallego S, Cresta Morgado P, Delgado-Serrano L, Simonetti S, Gonzalez M, Romero-Lozano P, et al. Homologous recombination repair status in metastatic prostate cancer by next-generation sequencing and functional immunofluorescence. Cell Reports Med. 2025 Feb 18;6(2):101937. |
| dc.identifier.issn | 2666-3791 |
| dc.identifier.uri | http://hdl.handle.net/11351/12845 |
| dc.description | Genòmica; Immunofluorescència; Càncer de pròstata |
| dc.description.sponsorship | This work was funded by an Impact Award from the Department of Defense CDMRP (PC170510P1) and a grant from AstraZeneca (ESR-21-21360). The funders had no role in the design or conduction of the study and were not involved in the analysis or interpretation of results. CRIS Cancer Foundation (grant TCL_2020-10) and Fundación AECC (LABAE20019MATE) and a Department of Defense Physician Science Award to J.M. (PC220307). S.A.-G. was supported by Instituto de Salud Carlos III (FI19/00280). P.C.M. was supported by an ESMO Translational Research Fellowship, funded by BMS (any views, opinions, findings, conclusions, or recommendations expressed in this material are those solely of the authors and do not necessarily reflect those of ESMO or BMS). I.C.-S. was supported by a Prostate Cancer Foundation YIA (24YOU12). A.L.-G. was supported by an AECC grant (INVES20095LLOP), and V.S. received funding from an ERA PerMed grant (ERAPERMED2019-215). The VHIO authors would like to acknowledge the Spanish State Agency for Research (Agencia Estatal de Investigación) for its financial support as a Center of Excellence Severo Ochoa (CEX2020-001024-S/AEI/10.13039/501100011033), the Cellex Foundation for providing research facilities and equipment, and the CERCA Program from the Generalitat de Catalunya for their support of this research. |
| dc.language.iso | eng |
| dc.publisher | Elsevier |
| dc.relation.ispartofseries | Cell Reports Medicine;6(2) |
| dc.rights | Attribution-NonCommercial-NoDerivatives 4.0 International |
| dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ |
| dc.source | Scientia |
| dc.subject | Anomalies cromosòmiques |
| dc.subject | Pròstata - Càncer - Aspectes genètics |
| dc.subject | Seqüència de nucleòtids |
| dc.subject | Metàstasi |
| dc.subject | ADN - Reparació |
| dc.subject.mesh | Mutation |
| dc.subject.mesh | Neoplasm Metastasis |
| dc.subject.mesh | Prostatic Neoplasms |
| dc.subject.mesh | /genetics |
| dc.subject.mesh | Recombinational DNA Repair |
| dc.subject.mesh | High-Throughput Nucleotide Sequencing |
| dc.title | Homologous recombination repair status in metastatic prostate cancer by next-generation sequencing and functional immunofluorescence |
| dc.type | info:eu-repo/semantics/article |
| dc.identifier.doi | 10.1016/j.xcrm.2025.101937 |
| dc.subject.decs | mutación |
| dc.subject.decs | metástasis neoplásica |
| dc.subject.decs | neoplasias de la próstata |
| dc.subject.decs | /genética |
| dc.subject.decs | reparación del ADN por recombinación |
| dc.subject.decs | secuenciación de nucleótidos de alto rendimiento |
| dc.relation.publishversion | https://doi.org/10.1016/j.xcrm.2025.101937 |
| dc.type.version | info:eu-repo/semantics/publishedVersion |
| dc.audience | Professionals |
| dc.contributor.organismes | Institut Català de la Salut |
| dc.contributor.authoraffiliation | [Arce-Gallego S, Delgado-Serrano L, Mir Arnau G, Aguilar D, Cordoba-Terreros S, Casanova-Salas I] Prostate Cancer Research, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. [Cresta Morgado P] Prostate Cancer Research, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. Oncology Data Science (OdysSey) Group, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. [Simonetti S, Nuciforo P] Molecular Oncology, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. [Gonzalez M, Marmolejo D, Morales-Barrera R, Suarez C, Carles J, Mateo J] Prostate Cancer Research, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. Servei d’Oncologia Mèdica, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. [Romero-Lozano P, Vivancos A] Cancer Genomics Group, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. [Semidey ME] Servei d’Anatomia Patològica, Vall d’Hebron Hospital Universitari, Barcelona, Spain. [Mast R, de Albert M] Servei de Radiodiagnòstic, Vall d’Hebron Hospital Universitari, Barcelona, Spain. [Planas J, Cuadras M] Servei d’Urologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. [Maldonado X] Servei d’Oncologia Radioteràpica, Vall d’Hebron Hospital Universitari, Barcelona, Spain. [Mas A, Nonell L] Bioinformatics Unit, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. [Dienstmann R] Oncology Data Science (OdysSey) Group, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. University of Vic - Central University of Catalonia, Vic, Spain. [Llop-Guevara A, Serra V] Experimental Therapeutics, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain |
| dc.identifier.pmid | 39914385 |
| dc.identifier.wos | 001433264900001 |
| dc.relation.projectid | info:eu-repo/grantAgreement/ES/PE2017-2020/FI19%2F00280 |
| dc.rights.accessrights | info:eu-repo/semantics/openAccess |